Myeloproliferative Neoplasm — Trials

Myeloproliferative Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

4,036 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 965
Recruiting: 553
Ph III recruiting: 55
Growth YoY: +9.2%
Industry share: 22%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 37.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (701)

clinicaltrialsPublishedShowing 101–150 of 281 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02935361	Guadecitabine and Atezolizumab in Treating Patients With Advanced Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia That Is Refractory or Relapsed	active not recruiting	Phase 1 / Phase 2	33	University of Southern CaliforniaOTHER	1	Jul 7, 2026	clinicaltrials
NCT04217356	Study of Stem Cell Transplant vs. Non-Transplant Therapies in High-Risk Myelofibrosis(ALLO-BAT)	active not recruiting	—	90	University Health Network, TorontoOTHER